- Previous Close
326.00 - Open
326.60 - Bid 315.20 x --
- Ask 331.00 x --
- Day's Range
322.20 - 327.00 - 52 Week Range
251.00 - 392.00 - Volume
20,361 - Avg. Volume
27,971 - Market Cap (intraday)
4.145B - Beta (5Y Monthly) 0.64
- PE Ratio (TTM)
31.45 - EPS (TTM)
10.29 - Earnings Date Aug 13, 2024
- Forward Dividend & Yield 3.00 (0.93%)
- Ex-Dividend Date Apr 22, 2024
- 1y Target Est
395.43
Tecan Group AG provides laboratory instruments and solutions for pharmaceutical, biotechnology and in-vitro diagnostic companies, university research departments, and diagnostic and other laboratories. It operates through Life Sciences Business and Partnering Business segments. The company offers liquid handling and automation, microplate readers and washers, consumables, NGS reagents, immunoassays and antibodies, and software; and Tecan Labwerx, an automation solution. It provides PARAMIT, a contract design and manufacturing service. The company operates in Switzerland, Europe, Other European countries, North America, Asia, and internationally. Tecan Group AG was founded in 1980 and is headquartered in Männedorf, Switzerland.
www.tecan.com3,315
Full Time Employees
December 31
Fiscal Year Ends
Sector
Medical Instruments & Supplies
Industry
Recent News: TECN.SW
Performance Overview: TECN.SW
Trailing total returns as of 6/14/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: TECN.SW
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: TECN.SW
Valuation Measures
Market Cap
4.14B
Enterprise Value
4.09B
Trailing P/E
31.42
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.86
Price/Book (mrq)
3.07
Enterprise Value/Revenue
3.81
Enterprise Value/EBITDA
19.88
Financial Highlights
Profitability and Income Statement
Profit Margin
12.29%
Return on Assets (ttm)
4.04%
Return on Equity (ttm)
9.76%
Revenue (ttm)
1.07B
Net Income Avi to Common (ttm)
132.07M
Diluted EPS (ttm)
10.29
Balance Sheet and Cash Flow
Total Cash (mrq)
366.42M
Total Debt/Equity (mrq)
23.48%
Levered Free Cash Flow (ttm)
124.75M